510(k) K212819

Disposable Biopsy Refill Needle by Suzhou Leapmed Healthcare Corporation — Product Code FCG

K212819 is an FDA 510(k) premarket notification submitted by Suzhou Leapmed Healthcare Corporation for the device "Disposable Biopsy Refill Needle". The FDA issued a decision of Substantially Equivalent on July 6, 2022. The device falls under product code FCG (Biopsy Needle), a Class II device regulated under 21 CFR 876.1075. Suzhou Leapmed Healthcare Corporation has at least 3 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 6, 2022
Date Received
September 3, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Biopsy Needle
Device Class
Class II
Regulation Number
876.1075
Review Panel
GU
Submission Type